custom image

Integrating Metabolism and Immunity

January 25-28, 2021 | 10:00AM EST | 3:00PM UTC | 4:00PM CET*
*Program is in development and subject to change


The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.

 Free Access to On Demand Content to Scientists from Low-and Middle-Income Countries

Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.

Apply Here

Traditionally, metabolism and immunity have been perceived as two distinct systems with distinct functions: metabolism regulates the disposal and transformation of nutrients, whereas the immune system is responsible for host defense. However, in a broader sense, these two processes are both an organism’s response to stressors, with the aim of restoring homeostasis. An increasing amount of evidence has demonstrated that the chronic activation of the immune system associated with overnutrition may be deleterious, contributing importantly to diabetes and long-term complications, such as cardiovascular disorders. Such dysregulation of the immune system may reflect the duration and magnitude of the metabolic stress, along with genetic predispositions. Accordingly, anti-inflammatory treatments of metabolic diseases emerge as therapies interfering with the pathogenesis of these illnesses and offer disease-modifying potential. Therefore, it is critical that clinical translation be based on an understanding of the physiology and pathophysiology of the role of the immune system in metabolism. This conference will bring together basic scientists and clinicians from both disciplines in order to spark innovative ways of understanding the interactions between the immune system and metabolism. The conference organizers anticipate that the conference will lead to the development of novel therapeutic concepts based on the pathways underlying the pathogenesis of diseases rather than on the manifestation of symptoms belonging to a specific clinical discipline.

Apply Here for Free On Demand Access


Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD


Abstract Submission:
‣ For Short Talk Consideration: Passed
‣ For Poster Booth: Passed
ePoster / SciTalk Submission: January 14, 2021
Financial Aid Application: Passed

*Please note, abstract submission is required
in order to submit an ePoster and/or Scitalk


Program Details

Speaking at this eSymposia

Janelle S. Ayres

The Salk Institute for Biological Studies, USA

Morris J. Birnbaum

Pfizer Inc., USA

Paul Cohen

Rockefeller University, USA

Elise Dalmas

INSERM, France

Vishwa Deep Dixit

Yale University, USA

Ana Domingos

University of Oxford, UK

Marc Y. Donath

University Hospital Basel, Switzerland

Helga Ellingsgaard

Centre for Physical Activity Research, Copenhagen, Denmark

Mark A. Febbraio

Monash Institute of Pharmaceutical Sciences, Australia

Ruth A. Franklin

Harvard University, USA

Christoph Hess

University Hospital Basel, Switzerland

Michael Karin

University of California, San Diego, USA

Eicke Latz

University of Bonn, Germany

Diane Mathis

Harvard Medical School, USA

Marina Mesquida

F. Hoffmann-La Roche Ltd, Switzerland

Evanna Mills

Dana-Farber Cancer Institute, USA

Matthias Nahrendorf

Massachusetts General Hospital, USA

Luke A. J. O'Neill

Trinity Biomedical Sciences Institute, Ireland

Gwendalyn J. Randolph

Washington University, USA

Alan R. Saltiel

University of California, San Diego, USA

Bruce M. Spiegelman

Harvard Medical School, USA

Rinke Stienstra

Wageningen University, Netherlands

Tom Thuren

Novartis Pharmaceuticals, USA

Bruce Verchere

University of British Columbia, Canada

Amy J. Wagers

Harvard University, USA

Jun Wu

University of Michigan, USA


This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community. Here, Debbie Johnson, our CEO, explains how we're going to do that.

The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.

Related Keystone Symposia In-Person Meetings

Explore all cancer-related meetings on the Keystone Symposia website.

custom image

custom image

custom image

Donate to Keystone Symposia

custom image